Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Estrogen Receptor Modulators Could Tackle Infectious Diseases
The results of a new study on drug repurposing indicate that the process may bring new hope in the battle against infectious diseases.
Survey Explores How Behavioral Model May Help Increase PrEP Use in At-Risk Groups
While the United States has seen significant increases in pre-exposure prophylaxis (PrEP) use among those at risk for HIV infection, PrEP uptake rates are still low overall in men who have sex with men, as well as in transgender individuals. A new study examines how a behavior model may help increase PrEP use in these at-risk groups.
PrEP Is Approved for Adolescents: Why Isn't it Being Prescribed More?
When taken consistently, PrEP can reduce the risk of HIV infection by 92%. So why aren’t more health care professionals prescribing it to adolescents, who continue to have an increased HIV incidence rate nationally?
New Clinical Practice Guidelines for Seasonal Influenza
Updated guidelines will hopefully spur more clinicians to test for and treat influenza in people with symptoms whether they’re high risk or not.
A Vicious Cycle of Antimicrobial Consumption and Resistance
Understanding the spiral of usage and resistance might help us stop prescribing practices that fuel AMR.
Vaxchora: What ID Pharmacists Should Know
The FDA approved the vaccine in 2016 for adults between the ages of 18 and 64 who are traveling to areas of active cholera transmission.
Flu Vaccination Rates in US Children Up 6.8% Over This Time Last Season
With early season flu vaccination rates up from 2017-2018 early season rates, new pediatric influenza deaths around the country are prompting health officials to call for even higher vaccination rates.
Pediatric Hexavalent Combination Vaccine Approved by FDA
The vaccine is approved as a 3-dose series, which consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.
Big advances in treatment can